Arch Venture Fund Vii, L.P. sold $489K of Syros Pharmaceuticals, Inc.

10% owner

Sold$489,280

$7.77Price

63,000Shares

−1%Stake

What SYRS did after the filing

Prices for SYRS after this filing aren't in yet.

Traded Mon, Jul 15. Filed Wed, Jul 17, 3:26 PM ET, during the session. Not investment advice.